A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in women with platinum-resistant/refractory ovarian cancerRobert W Holloway, Premal Thaker, Alberto A Mendivil, Sarfraz Ahmad, Ahmed N Al-Niaimi, James Barter, Tiffany Beck, Setsuko K Chambers, Robert L Coleman, Sarah M Crafton, Erin Crane, Ramez Eskander, Sharad Ghamande, Whitney Graybill, Thomas HerzogSee the full list of authors
4 September 2023
The KORE-INNOVATION trial, a prospective controlled multi-site clinical study to implement and assess the effects of an innovative peri-operative care pathway for patients with ovarian cancer: rationale, methods and trial designMelisa Guelhan Inci, Jalid Sehouli, Eva Schnura, Marlene Lee, Stephanie Roll, Thomas Reinhold, Julia Klews, Lutz Kaufner, Phil Niggemann, Harald Groeben, Julia Toelkes, Anett Reisshauer, Max Liebl, Enrico Daehnert, Manuela ZimmermannSee the full list of authors
19 May 2023
A prospective randomized controlled trial evaluating the safety and efficacy of patient blood management program in patients with gynecologic cancer (KGOG 4011/PBM)Jeong-Yeol Park, Ok Ju Kang, Yoo-Young Lee, Young Seok Kim
24 April 2023
TUBectomy with delayed oophorectomy as an alternative to risk-reducing salpingo-oophorectomy in high-risk women to assess the safety of prevention: the TUBA-WISP II study protocolMiranda P Steenbeek, Majke H D van Bommel, Joanna intHout, Christine B Peterson, Michiel Simons, Kit C B Roes, Marleen Kets, Barbara M Norquist, Elizabeth M Swisher, Rosella P M G Hermens, the TUBA-WISP II consortium, Karen H Lu, Joanne A de Hullu, the TUBA-WISP II consortium, Johan BultenSee the full list of authors
12 April 2023
Improving Endometrial cancer assessment by combining the new techniqUe of GENomic profiling with surgical Extra uterIne disEase assessment (EUGENIE)Jenneke C Kasius, Rita Trozzi, Johanna Pijnenborg, Thaïs Baert, Annouschka Laenen, Anne-Sophie Van Rompuy, Ignacio Zapardiel, Giuseppe Vizzielli, Jure Knez, Francesco Fanfani, Frédéric Amant
28 March 2023
Phase II activity trial of high-dose radiation and chemosensitization in patients with macrometastatic lymph node spread after sentinel node biopsy in vulvar cancer: GROningen INternational Study on Sentinel nodes in Vulvar cancer III (GROINSS-V III/NRG-GY024)Lilian T Gien, Brian Slomovitz, Ate Van der Zee, Maaike Oonk
18 January 2023
PARa-aOrtic LymphAdenectomy in locally advanced cervical cancer (PAROLA trial): a GINECO, ENGOT, and GCIG studyAlejandra Martinez, Fabrice Lecuru, Nicolò Bizzarri, Cyrus Chargari, Anne Ducassou, Anna Fagotti, Francesco Fanfani, Giovanni Scambia, David Cibula, Berta Díaz-Feijoo, Antonio Gil Moreno, Martina Aida Angeles, Mustafa Zelal Muallem, Christhardt Kohler, Mathieu LuyckxSee the full list of authors
30 January 2023
Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO clinical trial programRAINBO Research Consortium
20 December 2022
Patient outcomes following interval and delayed cytoreductive surgery in advanced ovarian cancer: protocol for a multicenter, international, cohort study (Global Gynaecological Oncology Surgical Outcomes Collaborative)Faiza Gaba, Karen Ash, Oleg Blyuss, Nicolò Bizzarri, Paul Kamfwa, Pedro T Ramirez, Ioannis C Kotsopoulos, Dhivya Chandrasekaran, Nana Gomes, John Butler, Marielle Nobbenhuis, Thomas Ind, Owen Heath, Desmond Barton, Arjun JeyarajahSee the full list of authors
15 November 2022
A multimodal prehabilitation program for the reduction of post-operative complications after surgery in advanced ovarian cancer under an ERAS pathway: a randomized multicenter trial (SOPHIE)Berta Díaz-Feijoo, Nuria Agusti, Raquel Sebio, Marina Sisó, Núria Carreras-Dieguez, Santiago Domingo, Oscar Díaz-Cambronero, Aureli Torne, Graciela Martinez-Palli, Ma José Arguís
6 July 2022
